Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Trying to understand Moores' response on claim 29.

Trying to understand Moores' response on claim 29.

posted on Jul 22, 2009 10:01AM

Moore's response regarding the recert of the '584 is interesting to say the least. On the one hand he acknowledges that the MMP still lives, yet on the other he implies the amended claim 29 is difficult to discern. Really? The inventor isn't exactly sure what the new amended claim 29 means? Any thoughts? He appears to be implying the amendment leaves the claims interpretation somewhat vague.

'584 Reexam

Claim 29 is patentable as amended. MMP lives!

Yet,

21 July Tuesday afternoon

I was just informed that after reexamination, US patent '584 was determined patentable. Claim 29, as amended. Thank you, Thomas. Really hard to know what Claim 29 says. I've added it to the Moore v TPL page.

Share
New Message
Please login to post a reply